Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Urology and Nephrology
Published in: International Urology and Nephrology 1/2007

01-03-2007 | Review Paper

An update on nutrition in chronic kidney disease

Authors: Denis Fouque, Fitsum Guebre-Egziabher

Published in: International Urology and Nephrology | Issue 1/2007

Login to get access

Abstract

The prevalence of malnutrition in the course of chronic kidney disease has not changed recently and is still between 30 and 50%. About 10% of patients on maintenance dialysis show signs of severe malnutrition. Recent progress has been made on protein metabolism, the validation of new diagnostic tools, and the use of anabolic compounds. Large clinical trials have characterized the use of medications for renutrition, and international guidelines are currently updated. Neverthless, physicians will be mostly efficient at the stage of malnutrition prevention, by implementing an early, interactive dietary and nutritional care programs in close collaboration with specialized dietitians.
Literature
1.
Aparicio M, Cano N, Chauveau P et al (1999) Nutritional status of haemodialysis patients: a French national cooperative study. French Study Group for Nutrition in Dialysis. Nephrol Dial Transplant 14:1679–1686PubMedCrossRef
2.
Clinical practice guidelines for nutrition in chronic renal failure (2000) K/DOQI, National Kidney Foundation. Am J Kidney Dis 35:S1–S140
3.
Rand WM, Pelett PL, Young VR (2003) Meta-analysis of nitrogen balance studies for estimating protein requirements in healthy adults. Am J Clin Nutr 77:109–127PubMed
4.
Ohkawa S, Kaizu Y, Odamaki M et al (2004) Optimum dietary protein requirement in nondiabetic maintenance hemodialysis patients. Am J Kidney Dis 43:454–463PubMedCrossRef
5.
Gutierrez A, Alvestrand A, Wahren J et al (1990) Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans. Kidney Int 38:487–494PubMed
6.
Bohe J, Rennie M (2006) Muscle protein metabolism during haemodialysis. J Renal Nutr 16:3–16CrossRef
7.
Raj DS, Welbourne T, Dominic EA et al (2005) Glutamine kinetics and protein turnover in end-stage renal disease. Am J Physiol Endocrinol Metab 288:E37–E46PubMedCrossRef
8.
Lim VS, Ikizler TA, Raj DS et al (2005) Does hemodialysis increase protein breakdown? Dissociation between whole-body amino acid turnover and regional muscle kinetics. J Am Soc Nephrol 16:862–868PubMedCrossRef
9.
Pupim LB, Flakoll PJ, Brouillette JR et al (2002) Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic hemodialysis patients. J Clin Invest 110:483–492PubMedCrossRef
10.
Raj DS, Zager P, Shah VO et al (2004) Protein turnover and amino acid transport kinetics in end-stage renal disease. Am J Physiol Endocrinol Metab 286:E136–E143PubMedCrossRef
11.
Pupim LB, Flakoll PJ, Ikizler TA (2004) Nutritional supplementation acutely increases albumin fractional synthetic rate in chronic hemodialysis patients. J Am Soc Nephrol 15:1920–1926PubMedCrossRef
12.
Veeneman JM, Kingma HA, Boer TS et al (2003) Protein intake during hemodialysis maintains a positive whole body protein balance in chronic hemodialysis patients. Am J Physiol Endocrinol Metab 284:E954–E965PubMed
13.
Burrowes JD, Larive B, Cockram DB et al (2003) Effects of dietary intake, appetite, and eating habits on dialysis and non-dialysis treatment days in hemodialysis patients: cross-sectional results from the HEMO study. J Renal Nutr 13:191–198CrossRef
14.
Bellizzi V, Di Iorio BR, Terracciano V et al (2003) Daily nutrient intake represents a modifiable determinant of nutritional status in chronic haemodialysis patients. Nephrol Dial Transplant 18:1874–1881PubMedCrossRef
15.
Laville M, Fouque D (2000) Nutritional aspects in hemodialysis. Kidney Int 76:S133–S139CrossRef
16.
Kloppenburg WD, Stegeman CA, Hooyschuur M et al (1999) Assessing dialysis adequacy and dietary intake in the individual hemodialysis patient. Kidney Int 55:1961–1969PubMedCrossRef
17.
Kloppenburg WD, Stegeman CA, De Jong PE et al (1999) Relating protein intake to nutritional status in haemodialysis patients: how to normalize the protein equivalent of total nitrogen appearance (PNA)? Nephrol Dial Transplant 14:2165–2172PubMedCrossRef
18.
Combe C, Chauveau P, Laville M et al (2001) Influence of nutritional factors and hemodialysis adequacy on the survival of 1,610 French patients. Am J Kidney Dis 37:S81–88PubMed
19.
Ohkawa S, Kaizu Y, Odamaki M et al (2004) Optimum dietary protein requirement in nondiabetic maintenance hemodialysis patients. Am J Kidney Dis 43:454–463PubMedCrossRef
20.
Chauveau P, Bourdenx J, Montaudon D et al (2004) Interaction between nutrition and inflammation in the Bordeaux study of inflammation in chronic hemodialysis patients (BICHE): 2 years follow-up. J Am Soc Nephrol 15:Abs
21.
Kaysen GA, Greene T, Daugirdas JT et al (2003) Longitudinal and cross-sectional effects of C-reactive protein, equilibrated normalized protein catabolic rate, and serum bicarbonate on creatinine and albumin levels in dialysis patients. Am J Kidney Dis 42: 1200–1211PubMedCrossRef
22.
Cano N (2004) Intradialytic parenteral nutrition: where do we go from here? J Renal Nutr 14:3–5CrossRef
23.
Stratton RJ, Bircher G, Fouque D et al (2005) Multinutrient oral supplements and tube feeding in maintenance dialysis: a systematic review and meta-analysis. Am J Kidney Dis 46:387–405PubMedCrossRef
24.
Foulks CJ (1999) An evidence-based evaluation of intradialytic parenteral nutrition. Am J Kidney Dis 33:186–192PubMed
25.
Czekalski S, Hozejowski R (2004) Intradialytic amino acids supplementation in hemodialysis patients with malnutrition: results of a multicenter cohort study. J Renal Nutr 14:82–88CrossRef
26.
Fouque D, Guebre-Egziabher F, Laville M (2003) Advances in anabolic interventions for malnourished dialysis patients. J Renal Nutr 13:161–165CrossRef
27.
Kopple JD, Brunori G, Leisorowitz M et al (2005) Growth hormone induces anabolism in malnourished maintenance haemodialysis patients. Nephrol Dial Transplant 20:952–958PubMedCrossRef
28.
Pupim LB, Flakoll PJ, Yu C et al (2005) Recombinant human growth hormone improves muscle amino acid uptake and whole-body protein metabolism in chronic hemodialysis patients. Am J Clin Nutr 82:1235–1243PubMed
29.
Fouque D, Peng SC, Shamir E et al (2000) Recombinant human insulin-like growth factor-1 induces an anabolic response in malnourished CAPD patients. Kidney Int 57:646–654PubMed
30.
English KM, Steeds RP, Jones TH et al (2000) Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled study. Circulation 102:1906–1911PubMed
31.
Hougaku H, Fleg JL, Najjar SS et al (2006) Relationship between androgenic hormones and arterial stiffness based on longitudinal hormone measurements. Am J Physiol Endocrinol Metab 290:E234–E242PubMedCrossRef
32.
Ferrando AA, Sheffield-Moore M, Yeckel CW et al (2002) Testosterone administration to older men improves muscle function: molecular and physiological mechanisms. Am J Physiol Endocrinol Metab 282:E601–607PubMed
33.
Bhasin S, Woodhouse L, Casaburi R et al (2001) Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab 281:E1172–1181PubMed
34.
Barton Pai A, Chretien C, Lau AH (2002) The effects of nandrolone decanoate on nutritional parameters in hemodialysis patients. Clin Nephrol 58:38–46PubMed
35.
Navarro JF, Mora C, Macia M et al (2002) Randomized prospective comparison between erythropoietin and androgens in CAPD patients. Kidney Int 61:1537–1544PubMedCrossRef
36.
Johansen KL, Mulligan K, Schambelan M (1999) Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial. JAMA 281:1275–1281PubMedCrossRef
37.
38.
Gascon A, Belvis JJ, Berisa F et al (1999) Nandrolone decanoate is a good alternative for the treatment of anemia in elderly male patients on hemodialysis. Geriatr Nephrol Urol 9:67–72PubMedCrossRef
39.
Suri RS, Garg AX (2006) Randomized trials of frequent hemodialysis: infinite possibilities. Blood Purif 24:123–127PubMedCrossRef
40.
Suri RS, Nersrallah GE, Mainra R et al (2006) Dialy hemodialysis: a systematic review. Clin J Am Soc Nephrol 1:33–42CrossRefPubMed
41.
Galland R, Traeger J, Arkouche W et al (2001) Short daily hemodialysis rapidly improves nutritional status in hemodialysis patients. Kidney Int 60:1555–1560PubMedCrossRef
42.
Galland R, Traeger J, Arkouche W et al (2001) Short daily hemodialysis and nutritional status. Am J Kidney Dis 37:S95–S98PubMed
43.
Batterham RL, Cohen MA, Ellis SM et al (2003) Inhibition of food intake in obese subjects by peptide YY3–36. N Engl J Med 349:941–948PubMedCrossRef
44.
Cheung W, Yu PX, Little BM et al (2005) Role of leptin and melanocortin signaling in uremia-associated cachexia. J Clin Invest 115:1659–1665PubMedCrossRef
45.
Mitch WE (2005) Cachexia in chronic kidney disease: a link to defective central nervous system control of appetite. J Clin Invest 115:1476–1478PubMedCrossRef
46.
Woods JD, Port FK, Orzol S et al (1999) Clinical and biochemical correlates of starting “daily” hemodialysis. Kidney Int 55:2467–2476PubMedCrossRef
47.
Buoncristiani U, Fagugli R, Pinciaroli M et al (1997) Control of aneamia by daily dialysis. J Am Soc Nephrol 8:216A
48.
Pinciaroli A (1998) Results of daily hemodialysis in Cantanzaro: 12-year experience with 22 patients treated for more than one year. Home Hemodialysis Int 2:12–17
49.
Kooistra MP, Vos J, Koomans HA et al (1998) Daily home haemodialysis in The Netherlands: effects on metabolic control, haemodynamics, and quality of life. Nephrol Dial Transplant 13:2853–2860PubMedCrossRef
50.
Lugon JR, Andre MB (2005) Initial Brazilian experience with short-duration in-center daily hemodialysis. Hemodial Int 9:3–6PubMedCrossRef
51.
Pierratos A, Ouwendyk M, Francoeur R et al (1998) Nocturnal hemodialysis: three-year experience. J Am Soc Nephrol 9:859–868PubMed
52.
McPhatter LL, Lockridge RS Jr, Albert J et al (1999) Nightly home hemodialysis: improvement in nutrition and quality of life. Adv Ren Replace Ther 6:358–365PubMed
53.
O’Sullivan DA, McCarthy JT, Kumar R et al (1998) Improved biochemical variables, nutrient intake, and hormonal factors in slow nocturnal hemodialysis: a pilot study. Mayo Clin Proc 73:1035–1045PubMedCrossRef
54.
Cacho C, Ferrara K, Guthrie B et al (2000) Slow Intensive Home Hemodialysis (SIHD): the University Hospitals of Cleveland experience. Nephrol News Issues 14:36–41PubMed
Metadata
Title
An update on nutrition in chronic kidney disease
Authors
Denis Fouque
Fitsum Guebre-Egziabher
Publication date
01-03-2007
Publisher
Kluwer Academic Publishers
Published in
International Urology and Nephrology / Issue 1/2007
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-006-9108-3

Other articles of this Issue 1/2007

International Urology and Nephrology 1/2007 Go to the issue

Original Paper

Intravesical explosions during transurethral endoscopic procedures

OriginalPaper

Nephrogenic adenoma of the ureter: Case report

Original Paper

Alternative strategies to evaluate the cost-effectiveness of peritoneal dialysis and hemodialysis

Original Paper

Is it worth using daclizumab induction therapy with mycophenolate mofetil-based immunosuppressive regimens in live related donor kidney transplantation? A long-term follow up

Original Paper

Conservative management of renal masses in the elderly: our experience

Original Paper

Palliative transarterial embolization of renal tumors in 20 patients
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits